Skip to main content
Clinical Trials/CTRI/2013/02/003427
CTRI/2013/02/003427Completed未知

A pilot study to determine the Imatinib adherence in CML patients and to find out the factors associated with non adherence : Single Centre Observational Questionnaire Based Study

Jyotsna Kapoor0 sites100 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1. willing to consent for participation in the study.
  • 2. Patients diagnosed with CML atleast 3 months from the start of the study.
  • 3.Treatment with Imatinib
  • 4. Those who can understand Hindi or English

Exclusion Criteria

  • 1. Patients who are either Dumb or deaf
  • 2. patients who have undergone allogenic stem cell transplantation
  • 3. patients taking another tyrosine kinase inhibitors besides Imatinib Mesylate

Investigators

Sponsor
Jyotsna Kapoor

Similar Trials